Ipsen – Consolidated Financial Statements – 2022

This article or press release has no online content. Please download the associated documents for more information.

Associated Documents

Ipsen_2022-Consolidated-Financial-Statements.pdf

Applications now open for the 2023 Golden Ticket Competition

Offering support to those impacted in Turkey & Syria

Ipsen delivers FY and Q4 2022 results – A word from CEO David Loew

J.P. Morgan Conference 2023: Ipsen shares strategy success

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2023